Literature DB >> 6772208

Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes.

R M Bartholomew, A F Esser.   

Abstract

Murine leukemia viruses activate human C1 in the absence of specific antibody. Such activation requires the binding of C1 to the viral surface through two subcomponents, C1q and C1s. This conclusion is based on the following results. (1) Isolated human C1q and C1s bind the same membrane protein on virions. (2) Binding one subcomponent is independent of the other. (3) Only dimeric C1s binds, whereas monomeric C1s, prepared by dissociation with ethylenediaminetetraacetate (EDTA), has no affinity for the virus. (4) The activated C1s dimer, C1s, does not attach to the virus. (5) Saturation of C1s binding sites on the viral surface does not prevent binding of macromolecular C1, but such bound C1 is not activated. (6) No exchange occurs between C1s bound to the viral membrane and C1s contained in C1, which in turn is attached via C1q to the same virus. Therefore activation occurs only when both C1q and C1s in the same C1 complex in contact with the viral activator. Human C1r has no affinity for the virus nor does guinea pig C1s. The latter result explains why guinea pig serum does not function in antibody-independent virolysis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772208     DOI: 10.1021/bi00554a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

Authors:  J E Schweinle; P J Hitchcock; A J Tenner; C H Hammer; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Gene therapy for cancers.

Authors:  L Lashford
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

Review 3.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

Review 6.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

7.  Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.

Authors:  C F Ebenbichler; N M Thielens; R Vornhagen; P Marschang; G J Arlaud; M P Dierich
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.

Authors:  B Aubert; S Chesne; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

9.  A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

Authors:  R P Rother; W L Fodor; J P Springhorn; C W Birks; E Setter; M S Sandrin; S P Squinto; S A Rollins
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.